Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers

Hepatic drug metabolizing enzymes (DMEs), whose activity may be affected by liver diseases, are major determinants of drug pharmacokinetics. Hepatitis C liver samples in different functional states, i.e., the Child–Pugh class A (n = 30), B (n = 21) and C (n = 7) were analyzed for protein abundances...

Descripción completa

Detalles Bibliográficos
Autores principales: Drozdzik, Marek, Lapczuk-Romanska, Joanna, Wenzel, Christoph, Skalski, Lukasz, Szeląg-Pieniek, Sylwia, Post, Mariola, Parus, Arkadiusz, Syczewska, Marta, Kurzawski, Mateusz, Oswald, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002520/
https://www.ncbi.nlm.nih.gov/pubmed/36901973
http://dx.doi.org/10.3390/ijms24054543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002520/
https://www.ncbi.nlm.nih.gov/pubmed/36901973
http://dx.doi.org/10.3390/ijms24054543

Ejemplares similares